Gene Query: DCN

Dataset Description Geneva Score
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 230.98
Role of CD133 molecule in WNT response and renal repair 202.43
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 179.2
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 112.91
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 111.5
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 92.1
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 92.1
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 91.33
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 90.34
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 89.26
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 84.38
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 83.48
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 78.83
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 78.59
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 76.87
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 74.27
High level DNA repair gene expression in human ES cells 74.0
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 73.84
Identification of the role of polydom in neurofibromas 67.39
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 66.39
Differential expression of genes in AD169-infected MRC5. 66.27
MCF10A H-Ras RNA-Seq 65.95
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 65.56
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 64.36
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 64.32
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 63.48
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 60.98
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 60.02
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 59.77
Maturation of human iNSCs 59.56
Investigation about fibroblasts of different origins in culture 58.7
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 57.29
Cerebellar differentiation in Ataxia-Telangiectasia 57.08
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 56.91
Nucleoporin-mediated regulation of cell identity genes 56.16
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 55.81
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 55.23
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 55.23
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 55.06
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 55.06
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 54.88
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 52.99
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 52.67
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 52.08
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 51.87
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 51.35
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 51.17
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 50.72
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 49.92
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 49.92
Identification of differentially expressed genes between senescence and senescence bypass cells 49.13
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 48.94
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 48.94
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 48.8
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 48.51
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 47.59
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 47.13
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 47.05
Inhibition of TNBC metastasis by Gpx1 47.04
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 46.46
Morphological and molecular characterization of human dermal lymphatic collectors 45.95
Evolution of a transcriptional regulator from a transmembrane nucleoporin 45.59
RNA-seq in HepG2 and IMR90 cells 45.59
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 45.57
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 45.29
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 45.16
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 45.07
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 44.73
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 44.51
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 43.04
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 42.98
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 42.31
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 42.08
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  41.84
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 41.2
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 40.94
Global analyses of the effect of different cellular contexts on microRNA targeting 40.75
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 40.75
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 40.24
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 39.58
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 39.54
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 39.21
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 39.16
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 39.09
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 38.91
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 38.6
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 38.35
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 37.08
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 37.08
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 37.02
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 35.6
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 35.33
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 35.33
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 34.25
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 34.08
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 33.94
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 33.76
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 33.51
High-efficiency RNA-based reprogramming of human primary fibroblasts 33.5
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 33.47
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 33.44
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 33.21
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 32.88
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 32.87
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 32.73
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 32.68
Gene expression profiling of human and murine in vitro muscle differentiation 32.63
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 32.53
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 32.38
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 32.0
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 31.94
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 31.94
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 31.93
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 31.93
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 31.36
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 31.29
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 31.2
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 31.13
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 31.11
Transcriptome analysis of H9 hESC derived cerebral organoids 30.98
Epigenome regulation during epidermal lineage commitment [RNA-seq] 30.96
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 30.5
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 30.43
Genome-wide chromatin analysis of Ewing sarcoma 30.27
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 30.27
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 29.84
RNA-seq of cells with TET1 knockout 29.68
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 29.66
An acquired vulnerability of drug resistant melanoma with therapeutic potential 29.66
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 29.57
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 29.47
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 29.33
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 29.32
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 29.01
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 28.8
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 28.63
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 28.14
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 27.98
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 27.9
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 27.8
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 27.59
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 27.52
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 27.4
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 27.25
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 27.24
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 26.68
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 26.68
Genome-wide Analysis of Chromatin Interactions in Human Cells 26.59
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 26.4
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 26.24
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 26.09
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 25.87
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 25.87
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 25.85
Dynamic reorganization of nuclear architecture during human cardiogenesis 25.85
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 25.31
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 25.06
RNA sequencing of human mammary epithelial cells 24.88
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 24.79
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 24.75
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 24.68
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 24.2
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 24.19
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 24.09
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 23.9
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 23.87
Changes in human endometrial gland transcriptome over the window of implantation 23.7
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 23.64
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 23.46
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 23.06
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 23.06
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 22.9
RNA-seq of stable and unstable section of human atherosclerotic plaques 22.89
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 22.66
Nutritional control of protein translation 22.51
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 22.47
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 22.47
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 22.04
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 21.94
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 21.8
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 21.52
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 21.52
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 21.49
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 21.48
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 21.04
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 20.8
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 20.75
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 20.63
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 20.58
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 20.15
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 19.99
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 19.65
Gene expression patterns define the hepatocyte-like cells derived by different strategies 19.65
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 19.45
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 19.43
Transcriptomes in healthy and CHB fetal hearts 19.39
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 19.34
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 19.25
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 19.2
RNA-sequencing of human liver tissue 18.98
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 18.81
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 18.54
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 18.54
Generating Patterned Kidney Organoids for Studying Development and Diseases 18.35
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 18.08
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 18.04
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 17.9
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 17.81
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 17.77
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 17.73
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 17.65
Derivation and differentiation of haploid human embryonic stem cells 17.6
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 17.56
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 17.56
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 17.49
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 17.49
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 17.39
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 17.39
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 17.34
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 17.12
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 16.94
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 16.92
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 16.91
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 16.81
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 16.74
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 16.47
Comparing gene expression in iPSC derived RPE from control and AMD donors 16.46
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 16.32
Expression by CD133+ cells isolated from the adult human exocrine pancreas 16.23
CHCHD10 gene KO effect in iPSC drived motor neurons 16.2
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 16.16
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 16.11
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 16.0
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 16.0
STX4 Over-Expression in Human islets 15.99
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 15.98
RNA-sequencing of formalin fixed human primary melanoma tissue 15.96
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 15.94
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 15.86
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 15.79
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 15.77
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 15.39
The role of CFTR in islet function 15.33
The age and genomic integrity of neurons after cortical stroke in humans 15.23
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 15.11
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 15.11
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 15.11
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 15.05
Epigenomic landscape during organ formation in human early embryos 14.97
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 14.94
14.87
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 14.86
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 14.68
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 14.67
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 14.64
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 14.61
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 14.37
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 14.26
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 13.95
Transcriptome analyses of human pancreatic islets and pseudoislets 13.9
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 13.88
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 13.72
Gene expression profile in breast cancer cell lines using RNA sequencing 13.69
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 13.06
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 13.01
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 13.0
RNA-seq of MCF10A cells and CAF 12.91
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 12.89
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 12.85
NKX2.2 12.85
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 12.72
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 12.55
Transcriptomic profile of human embryonic renal corpuscles 12.54
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 12.53
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 12.5
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 12.5
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 12.49
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 12.49
Gene expression profiling of papillary thyroid cancer from central and invasive regions 12.43
iPSC derived motor neuron cultures from C9ORF72 carriers 12.42
Non-coding regions are the main source of tumor-specific antigens [human] 12.4
Non-coding regions are the main source of tumor-specific antigens 12.4
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 12.26
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 11.81
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 11.81
Next Generation Sequencing of human SMA and healthy control Motor Neurons 11.72
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 11.7
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 11.7
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 11.68
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 11.66
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 11.57
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 11.55
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 11.45
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 11.23
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 11.15
Neonatal and adult human testis defined at the single-cell level 11.13
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 10.96
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 10.96
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 10.92
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 10.91
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 10.91
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 10.76
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 10.74
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 10.69
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 10.69
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 10.69
Single cell transcriptome of peritoneal cells 10.63
Postnatal lipids drive hepatocyte maturation 10.59
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 10.52
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 10.49
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 10.47
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 10.47
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 10.45
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 10.44
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 10.34
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 10.29
Hepatosplenic T cell lymphoma 10.12
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 10.12
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 10.11
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 9.87
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 9.87
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 9.77
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 9.58
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 9.58
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 9.56
Human islets of varying quality: the good, the (not so) bad and the ugly 9.55
In vitro modeling of human germ cell development using pluripotent stem cells 9.38
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 9.31
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 9.31
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 9.28
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 9.21
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 9.19
Characterization of the Merkel cell carcinoma miRNome 9.17
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 9.06
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 8.97
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 8.81
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 8.81
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 8.63
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 8.61
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 8.6
iPSC-Derived Cholangiocytes 8.5
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 8.35
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 8.22
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 8.21
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 8.14
Microglia innatly develop within cerebral organoids 8.08
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 8.07
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 8.07
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 7.83
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 7.83
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 7.8
ENCODE Cold Spring Harbor Labs Long RNA-seq 7.68
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 7.67
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 7.62
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 7.49
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 7.48
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 7.43
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 7.43
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 7.43
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 7.43
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 7.33
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 7.21
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 7.14
Expression profiles of the four human major ectodermal lineages 7.14
Efficient derivation of microglia-like cells from human pluripotent stem cells 6.99
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 6.97
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 6.97
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 6.92
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 6.9
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 6.89
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 6.84
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 6.82
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 6.77
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 6.67
RNA-seq melanoma 6.63
Hepatic transcriptome of pediatric hepatoblastoma. 6.62
Molecular analysis of renal cell carcinoma with unclassfied histology 6.56
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 6.56
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 6.55
Alagille_Nodder 6.54
RNA Seq of Alagille liver biopsies 6.54
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 6.54
circRNA-sequencing 6.51
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 6.47
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 6.45
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 6.45
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 6.43
The DNA methylation landscape of human melanoma [RNA-Seq] 6.4
The DNA methylation landscape of human melanoma 6.4
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 6.38
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 6.37
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 6.36
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 6.24
MicroRNA targetome analysis during HCMV infection 6.18
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 6.15
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 6.04
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 6.02
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 5.95
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 5.95
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 5.92
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 5.81
RNA-seq analysis of the human fetal kidney. 5.8
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 5.77
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 5.67
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 5.59
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 5.54
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 5.54
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 5.5
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 5.35
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 5.35
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 5.35
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 5.35
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 5.35
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 5.19
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 5.14
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 5.14
Epigenome regulation during epidermal lineage commitment 5.05
RNA-seq of shEZH2 cells 5.01
The gene expression profiles of gallbladder cancer 5.0
circNFIB suppresses lymphatic metastasis of pancreatic cancer 4.89
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 4.77
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 4.69
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 4.69
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 4.58
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 4.48
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 4.47
Modeling Familial Cancer with iPSC Approaches 4.39
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 4.35
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 4.22
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 4.17
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 4.14
CUREfast: Accelerating research with families 4.09
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 3.98
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 3.98
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 3.93
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 3.88
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 3.87
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 3.84
Patient-derived xenograft platform for metastatic melanoma 3.84
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 3.81
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 3.8
RNA-Seq of Breast and Ovarian Cancer Cell Lines 3.74
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 3.6
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 3.59
RNA-sequencing 3.51
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 3.3
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 3.3
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 3.26
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 3.17
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 3.15
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 3.11
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 3.03
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 2.97
Metabolism as an early predictor of DPSCs aging 2.93
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 2.81
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 2.79
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 2.74
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 2.53
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 2.43
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 2.4
Zika virus infection reprograms global transcription of host cells to allow sustained infection 2.24
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 2.21
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 1.95
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 1.91
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 1.73
Selective expression of long non-coding RNAs in a breast cancer cell progression model 1.7
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 1.6
Engineering Patient-Specific Tissue Implants 1.52
Gene expression profiling in metabolically heterogeneous human lung tumors 1.52
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 1.45
High-resolution comparative analysis of great ape genomes 1.44
RNA-Seq in PWS iPSC-derived neurons 1.43
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 1.41
RNA-Seq and expression data from human adipose tissue 1.4
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 1.4
Functional astrocytes differentiated from hiPSCs 1.34
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 1.3
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 1.12
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 1.09
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 1.09
RNA-sequencing of healthy human skeletal myocytes 0.85
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.74
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.74
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 0.74
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.57
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.54
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.53
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.52
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.52
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 0.47
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 0.34
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 0.33
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 0.33
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 0.32
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.25
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 0.2
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 0.2
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 0.18
Differences in miRNA Detection Levels are Technology and Sequence Dependent 0.08
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 0.08


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation